Landscapes / Targets
HDAC
14 drugs act on HDAC, in 32 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs14
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Givinostat Hydrochloridenot checked |
Histone deacetylase inhibitor |
Approved | Dec 2026Phase 2 trial completes | ||
| How it works | Blocks HDAC enzymes | ||||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy, Chronic Myeloproliferative Neoplasms and 1 more | ||||
| Open drug page | |||||
— |
Approved in China | 31 May 2028Phase 3 trial completes | |||
| Next date | 31 May 2028 · Phase 3 trial completes | ||||
| Also tested for | Colorectal Cancer, Lymphoma, T-Cell, Peripheral | ||||
| Open drug page | |||||
Histone deacetylase inhibitor |
Approved | Jul 2030Phase 3 trial completes | |||
| How it works | Blocks HDAC enzymes | ||||
| Next date | Jul 2030 · Phase 3 trial completes | ||||
| Also tested for | Peripheral T Cell Lymphoma | ||||
| Open drug page | |||||
— |
Approved in Japan | — | |||
| Also tested for | Unresectable or Metastatic Melanoma, Progressive Brain Metastasis | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Dec 2026Phase 3 trial completes | |||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Renal Cell Carcinoma, Follicular Lymphoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Dec 2026Phase 2 trial completes | |||
| Next date | 30 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Diffuse Large B Cell Lymphoma,DLBCL, Advanced Solid Tumor and 5 more | ||||
| Open drug page | |||||
— |
Phase 2 | Jun 2027Phase 2 trial completes | |||
| Next date | Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Relapsed or Refractory Peripheral T-cell Lymphoma | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Hematologic Malignancies, Onychomycosis of Toenail | ||||
| Open drug page | |||||
— |
Phase 1/2 | 28 Mar 2028Phase 1/2 trial completes | |||
| Next date | 28 Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Malignant Neoplasm of Brain, Malignant Neoplasm and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2028Phase 1/2 trial completes | |||
| Next date | Apr 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2028Phase 2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Adenoid Cystic Carcinoma, Head and Neck Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Jan 2031Phase 1/2 trial completes | |||
| Next date | 30 Jan 2031 · Phase 1/2 trial completes | ||||
| Also tested for | Essential Thrombocythemia (ET), Polycythemia Vera | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Metastatic Pancreatic Adenocarcinoma | ||||
| Open drug page | |||||
Vorinostatnot checked |
Histone deacetylase inhibitor |
Phase 1 | 31 Dec 2026Phase 1 trial completes | ||
| How it works | Blocks HDAC enzymes | ||||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Rett Syndrome, Pitt Hopkins Syndrome | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 12 of 14 drugs. The other 2 are marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026